Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.09.2020 | Case report

Dupilumab

Psoriatic erythroderma: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Gambichler T, et al. Dupilumab-induced psoriatic erythroderma with characteristic cytokine and antimicrobial peptide expression pattern in a patient with long standing atopic dermatitis. International Journal of Dermatology 59: 1160-1162, No. 9, Sep 2020. Available from: URL: http://doi.org/10.1111/ijd.15003 Gambichler T, et al. Dupilumab-induced psoriatic erythroderma with characteristic cytokine and antimicrobial peptide expression pattern in a patient with long standing atopic dermatitis. International Journal of Dermatology 59: 1160-1162, No. 9, Sep 2020. Available from: URL: http://​doi.​org/​10.​1111/​ijd.​15003
Metadaten
Titel
Dupilumab
Psoriatic erythroderma: case report
Publikationsdatum
01.09.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-83478-x

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Rituximab

Case report

Warfarin

Case report

Teicoplanin

Case report

Levofloxacin